Apparatus and method for determination of the adequacy of dialysis by non-invasive near-infrared spectroscopy
AssigneeRio Grande Medical Technologies, Inc.
InventorMark Ries Robinson
Life of this patent
Estimating the term…
Loading patent…
AssigneeRio Grande Medical Technologies, Inc.
InventorMark Ries Robinson
Estimating the term…
Methods and apparatus for non-invasive tissue urea concentrations during or subsequent to hemodialysis using near-infrared spectroscopy are discussed. Near-infrared tissue spectra can be obtained by projecting near-infrared radiation into skin on the underside of human forearms and capturing the light reflected back and out through the tissue. An index matching medium is used to couple the tissue to the analyzer. The tissue spectrum collected preferably includes primarily diffuse reflected light reflected from the inner dermis. Multiple tissue spectra of known urea concentration are used to build a model from which the urea concentration of an unknown sample can be devised. The model is based on a partial least squares algorithm applied to multiple tissue scans and concomitant blood sample urea measurements. This model is then applied to an unknown tissue spectra.
A method for assessing the need for hemodialysis, the progress of a hemodialysis procedure or the adequacy of a hemodialysis treatment, said method comprising the steps of:
A non-invasive method for measuring the concentration of urea in human tissue comprising the steps of:
A non-invasive method for measuring the concentration of urea in human tissue comprising the steps of:
Dependencies are inferred from the claim text.